These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 33012423)
1. SIRT6/LncRNA-MALAT1: A potential mechanism for treating aging-associated vascular diseases. He X; Ou C Int J Cardiol; 2020 Nov; 319():139. PubMed ID: 33012423 [No Abstract] [Full Text] [Related]
2. SIRT6-mediated transcriptional suppression of MALAT1 is a key mechanism for endothelial to mesenchymal transition. Qin W; Zhang L; Li Z; Xiao D; Zhang Y; Yang H; Liu X; Zhang H; Chen X; Xu C; Yang B; Zhang Y Int J Cardiol; 2019 Nov; 295():7-13. PubMed ID: 31399301 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22. Song Y; Yang L; Guo R; Lu N; Shi Y; Wang X Biochem Biophys Res Commun; 2019 Feb; 509(2):359-366. PubMed ID: 30591217 [TBL] [Abstract][Full Text] [Related]
4. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145. Xiang Y; Zhang Y; Tang Y; Li Q Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533 [TBL] [Abstract][Full Text] [Related]
5. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2. Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878 [TBL] [Abstract][Full Text] [Related]
6. LncRNA MALAT1 up-regulates VEGF-A and ANGPT2 to promote angiogenesis in brain microvascular endothelial cells against oxygen-glucose deprivation via targetting Ren L; Wei C; Li K; Lu Z Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30038058 [TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis. Luo L; Wang Y; Hu P; Wu J Med Sci Monit; 2020 Mar; 26():e920478. PubMed ID: 32222724 [TBL] [Abstract][Full Text] [Related]
8. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract. Lu L; Luo F; Liu Y; Liu X; Shi L; Lu X; Liu Q Toxicol Appl Pharmacol; 2015 Dec; 289(2):276-85. PubMed ID: 26415832 [TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 Promotes STAT3-Mediated Endothelial Inflammation by Counteracting the Function of miR-590. Zhou Q; Run Q; Li CY; Xiong XY; Wu XL Cytogenet Genome Res; 2020; 160(10):565-578. PubMed ID: 33022677 [TBL] [Abstract][Full Text] [Related]
10. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling. He B; Peng F; Li W; Jiang Y J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of lncRNA MALAT1 alleviates vascular lesion and vascular remodeling of rats with hypertension. Xue YZ; Li ZJ; Liu WT; Shan JJ; Wang L; Su Q Aging (Albany NY); 2019 Jul; 11(14):5192-5205. PubMed ID: 31343412 [TBL] [Abstract][Full Text] [Related]
12. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis. Liu B; Qiang L; Wang GD; Duan Q; Liu J Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related]
14. Long non‑coding RNA MALAT1 sponges miR‑124‑3p.1/KLF5 to promote pulmonary vascular remodeling and cell cycle progression of pulmonary artery hypertension. Wang D; Xu H; Wu B; Jiang S; Pan H; Wang R; Chen J Int J Mol Med; 2019 Sep; 44(3):871-884. PubMed ID: 31257528 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p. Hou J; Wang L; Wu Q; Zheng G; Long H; Wu H; Zhou C; Guo T; Zhong T; Wang L; Chen X; Wang T Stem Cell Res Ther; 2018 Apr; 9(1):109. PubMed ID: 29673400 [TBL] [Abstract][Full Text] [Related]
16. Correlation Between Single Nucleotide Polymorphisms of the rs664589 Locus in the Long-Chain Noncoding RNA Lung Adenocarcinoma Metastasis-Associated Gene 1, Hypertension, and Its Mechanism. Mou X; Wang J; Wang L; Wang S Genet Test Mol Biomarkers; 2020 Mar; 24(3):120-130. PubMed ID: 32109146 [No Abstract] [Full Text] [Related]
17. [Mechanism of long non-coding RNA-metastasis associated lung adenocarcinoma transcript 1 induced invasion and metastasis of esophageal cancer cell EC-109]. Zhang QQ; Cui YH; Wang Y; Kou WZ; Cao F; Cao XJ; Miao ZH; Kang XH Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):405-411. PubMed ID: 28635228 [No Abstract] [Full Text] [Related]
18. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis. Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072 [No Abstract] [Full Text] [Related]
19. Long noncoding RNA Malat1 is a potent autophagy inducer protecting brain microvascular endothelial cells against oxygen-glucose deprivation/reoxygenation-induced injury by sponging miR-26b and upregulating ULK2 expression. Li Z; Li J; Tang N Neuroscience; 2017 Jun; 354():1-10. PubMed ID: 28433650 [TBL] [Abstract][Full Text] [Related]